Ask Warren

DongKoo Bio & Pharma

006620 · KOSDAQ · ₩006620 · 동구바이오제약

₩3,310▲ ₩125 (3.92%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • 5%+ holding report주식등의대량보유상황보고서(일반)

    Predicted impact: Low

    Oct 29, 2026Open on DART
  • Share cancellation decision주식소각결정

    Predicted impact: Medium

    Share cancellation of own shares, about 1 percent or less of market value implied.

    Oct 28, 2026Open on DART
  • Trust Contract Termination Result Report신탁계약해지결과보고서

    Predicted impact: Low

    Trust termination for buyback; buyback size not given and related cancellation already reported.

    Oct 28, 2026Open on DART
  • Material Matters Report (Decision on Termination of Trust Agreement for Own Share Acquisition)주요사항보고서(자기주식취득신탁계약해지결정)

    Predicted impact: Medium

    Termination of a own-share trust is a buyback change worth about 0.1% of market value, so smaller.

    Oct 28, 2026Open on DART
  • Status Report on Acquisition Under Trust Agreement신탁계약에의한취득상황보고서

    Predicted impact: Low

    Oct 22, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)

    Predicted impact: Low

    Oct 19, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Oct 8, 2026Open on DART
  • [Amended Filing] Major Matters Report (Business Suspension)[기재정정]주요사항보고서(영업정지)Oct 8, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 15, 2026Open on DART
  • [Amended Filing] Major Matters Report (Business Suspension)[기재정정]주요사항보고서(영업정지)Sep 10, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 2, 2026Open on DART
  • [Amended Filing] Major Matters Report (Business Suspension)[기재정정]주요사항보고서(영업정지)Aug 18, 2026Open on DART
  • [Amended Filing] Major Matters Report (Business Suspension)[기재정정]주요사항보고서(영업정지)Aug 18, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 12, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Aug 4, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jul 27, 2026Open on DART
  • Buyback trust contract signed주요사항보고서(자기주식취득신탁계약체결결정)Jul 22, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jul 15, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jul 7, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jun 29, 2026Open on DART
  • Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Jun 25, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jun 11, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jun 5, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)May 26, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)May 13, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Apr 2, 2026Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Apr 1, 2026Open on DART
  • Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Apr 1, 2026Open on DART
  • Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART
  • Audit report submitted감사보고서제출Mar 23, 2026Open on DART
  • Annual report (Dec 2025)사업보고서 (2025.12)Mar 23, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의Mar 16, 2026Open on DART
  • Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Mar 16, 2026Open on DART
  • Cash dividend decision현금ㆍ현물배당결정Mar 16, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Mar 16, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 16, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jan 20, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jan 12, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Dec 22, 2025Open on DART
  • [Amended Filing] Closure of Shareholder Register for Cash and Stock Dividends (Record Date) Decision[기재정정]현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정Dec 12, 2025Open on DART
  • Shareholder Register Closure for Cash/Stock Dividend (Record Date) Decision현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정Dec 12, 2025Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 12, 2025Open on DART
  • Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Nov 12, 2025Open on DART
  • Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
  • Merger Completion Report (Merger)합병등종료보고서(합병)Jul 2, 2025Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jun 18, 2025Open on DART
  • Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Apr 30, 2025Open on DART

Titles in Korean until English translations are added.

Also known as: DongKoo Bio & Pharma / 동구바이오제약 / 006620 / KRX:006620

Source: KRX statistical information